Key Takeaways CNC reported Q2 adjusted loss of 16 cents/share, missing estimates and down from year-ago profit of $2.42.Rising medical costs and lower Medicare and Medicaid membership pressured CNC's bottom line.Revenues rose 22.4% to $48.7B, driven by premium growth, PDP business strength and Medicaid rate hikes.Centene Corporation (CNC) reported second-quarter 2025 adjusted loss per share of 16 cents, which missed the Zacks Consensus Estimate of earnings of 68 cents, a rare feat. Moreover, the bottom line ...

Centene (CNC) Q2 2025 Earnings Call July 25, 2025 08:00 AM ET Speaker0Good morning, and welcome to the Centene Corporation Second Quarter Earnings Conference Call. All participants will be in listen only mode. After today's presentation, there will be an opportunity to ask questions. Please note today's event is being recorded. Would now like to turn the conference over to Jennifer Gilligan, Senior Vice President, Finance and Investor Relations.Please go ahead, ma'am.Speaker1Thank you, Rocco, and good morni ...

Deploy Polkadot Native Rollups in a single click.This man is making it happen.@SantiBalaguerThe Kus (@TheKusamarian):S P A C E M O N K E Y S ˄͎ PodcastDeploy Powerful Rollups ⚡️→ Polkadot Deployment Protocolfeat. @SantiBalaguerw/ @GldnCalfShow Notes:Discover how Polkadot’s Deployment Portal (PDP) is rewriting powerful blockchain development by simplifying rollup launches.In this https://t.co/nD1rvBWK2e ...

行业研究丨深度报告丨家用电器 [Table_Title] 如何看显示技术迭代对黑电格局和盈利的影 响？ %% %% %% %% research.95579.com 1 丨证券研究报告丨 报告要点 [Table_Summary] 复盘上一轮显示技术变迁（从 CRT 升级至 LCD），全球市场来看，韩企三星、LG 通过逆周期 投资 LCD 面板实现对日企的超越， 2006 年三星液晶电视销量和销额市占率均为全球第一。中 国市场来看，海信视像准确把握 LCD 技术渗透契机，优化产品结构，实现电视业务毛利率提 升。本轮 Mini LED 升级趋势明确，中国企业在 Mini LED 技术研发上持续加码。大陆面板厂份 额扩大，叠加 Mini LED 电视产品面板成本占比较普通 LCD 产品更低。基于此，我们认为中国 黑电企业在本轮技术迭代中盈利能力和全球份额的提升具备可持续性。 分析师及联系人 [Table_Author] 陈亮 SAC：S0490517070017 SFC：BUW408 请阅读最后评级说明和重要声明 2 / 23 %% %% %% %% research.95579.com 2 [Table_Titl ...

大屏幕拼接系统是由单套投影显示单元组合拼接而成的高亮度、高分辨率、色彩还原准确的电视墙。其 核心器件包括P光学引擎、图像处理器等，并通过图像控制软件对显示画面实施控制。其功能强大，能 显示各种计算机(工作站)、网络信号及各种视频信号，画面能任意漫游、开窗、放大缩小和迭加。大屏 幕拼接系统主要由三部分组成：大屏幕投影墙、投影机阵列、控制系统。其中控制系统是核心，世界上 流行的拼接控制系统主要有四种类型：硬件拼接系统、软件拼接系统、软件与硬件相结合的拼接系统、 嵌入式硬件拼接系统。这些不同类型的控制系统，各自有着独特的应用特点和优势，为各种复杂的应用 场景提供了灵活多样的解决方案。 关键词：大屏幕拼接系统、显示面板、智慧交通、市场规模 内容概要：大屏幕拼接系统行业近年来发展迅猛，已经成为信息可视化不可或缺的核心基础系统。社会 对信息化需求的不断增长，特别是在一些监控中心、指挥中心、调度中心等重要场所，单台显示设备所 能显示的信息已经远远不能满足市场需求。因此，大屏幕拼接系统应运而生，并广泛应用于安防监控、 指挥调度、会议室、展示中心等多个领域。得益于国内大型活动、体育赛事、商业展示等对高清晰度、 超大显示的需求不 ...

Humana Inc. (HUM) reported first-quarter 2025 adjusted earnings of $11.58 per share, which outpaced the Zacks Consensus Estimate by 16%. The bottom line soared 60.2% year over year. (See the Zacks Earnings Calendar to stay ahead of market-making news.)Adjusted revenues improved 9.5% year over year to $32.1 billion. However, the top line missed the consensus mark by 0.3%. The quarterly results benefited on the back of strong premiums resulting from an expanding customer base in stand-alone prescription drug ...

Core Viewpoint - Humana Inc. is expected to report strong first-quarter 2025 results, with earnings projected at $9.98 per share and revenues at $32.22 billion, indicating significant year-over-year growth [1][3]. Financial Performance - The first-quarter earnings estimate reflects a 38% year-over-year increase, while revenues are expected to grow by 9.8% [1]. - For the current year, Humana's revenue consensus estimate stands at $126.55 billion, representing an 8% year-over-year rise, and the EPS consensus is $16.36, indicating a growth of approximately 0.9% [3]. Earnings Expectations - Humana has consistently beaten earnings estimates in the past four quarters, with an average surprise of 15.4% [3]. - The company has a positive Earnings ESP of +0.57% and a Zacks Rank of 3 (Hold), suggesting a likelihood of an earnings beat this quarter [4]. Revenue Drivers - Revenue growth in Q1 is anticipated to be driven by higher premiums, with the consensus estimate for premiums at $30.7 billion, reflecting an 8.6% year-over-year increase [5]. - Revenues from Medicare stand-alone PDPs are expected to reach $1.7 billion, indicating a substantial year-over-year increase of 110.8% [5]. Membership Trends - Despite the expected revenue growth, total medical memberships are projected to decline by 3.8% year-over-year, primarily due to decreases in individual Medicare Advantage units and ASO commercial memberships [6]. Operating Expenses - Total operating expenses for the Insurance segment are estimated to grow by 7.6% year-over-year, attributed to higher operating costs [7].

Centene Corporation (CNC) reported first-quarter 2025 adjusted earnings per share (EPS) of $2.90, which surpassed the Zacks Consensus Estimate by 22.9%. Moreover, the bottom line climbed 28% year over year. (See the Zacks Earnings Calendar to stay ahead of market-making news.)Revenues advanced 15.4% year over year to $46.6 billion. The top line beat the consensus mark by 7.2%.The quarterly results benefited on the back of solid premium growth fueled by expanding membership in the Prescription Drug Plan (PDP ...

Financial Data and Key Metrics Changes - The company reported first quarter adjusted diluted EPS of $2.90, consistent with previous expectations, with full-year 2025 adjusted EPS expectations remaining unchanged at greater than $7.25 [5][24][37] - Premium and service revenue for Q1 was $42.5 billion, with an increase in full-year revenue guidance to a midpoint of $165 billion, up from $159 billion [26][38] - The adjusted SG&A expense ratio decreased to 7.9% from 8.7% year-over-year, driven by revenue growth and expense discipline [35] Business Line Data and Key Metrics Changes - Medicaid membership was stable at approximately 12.9 to 13 million members, with a Medicaid HBR of approximately 93%, showing slight improvement from 93.4% in Q4 2024 [27][28] - The Medicare segment performed in line with expectations, with Medicare Advantage membership contributing an additional $1 billion to the 2025 revenue outlook due to better-than-expected retention [16][31] - The commercial segment saw strong growth, with a Q1 HBR of 75.0%, up from 73.3% the previous year, driven by new marketplace members [34] Market Data and Key Metrics Changes - The company noted an increase in bipartisan support for extending health care premium tax credits, with 78% of swing voters supporting the extension [9] - The expiration of enhanced premium tax credits is anticipated to be addressed by Congress, with significant implications for the marketplace [10][23] - The company is preparing for potential impacts from proposed marketplace integrity and affordability rules, which could influence market dynamics starting in 2026 [22][42] Company Strategy and Development Direction - The company is focused on margin recovery and aligning rates with member acuity, with expectations that Medicaid will return to pre-pandemic margin levels [11][13] - Strategic initiatives include expanding Medicaid managed care into rural areas and enhancing the Medicare Advantage value proposition [14][16] - The company is committed to navigating the evolving policy landscape while advocating for sound health care policy [7][11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to manage through a dynamic policy landscape, noting that broad support for Medicaid benefit cuts is lacking [7][8] - The company anticipates continued momentum in discussions with state partners regarding rate negotiations and acuity data [75] - Management remains optimistic about long-term growth prospects, emphasizing the attractiveness of end markets and the potential for market share capture [24][25] Other Important Information - The company experienced $130 million in incremental medical expenses due to an active flu season, which offset underlying improvements in medical loss ratio [12][28] - The company is actively engaging with CMS on proposed rules that could impact the marketplace and is preparing for various potential outcomes [22][23] Q&A Session Summary Question: Details on flu-related costs - Management clarified that the $130 million in flu-related costs was tracked using a consistent definition and was isolated to Medicaid, with some flu impact seen in Medicare but not at the same level [49][51] Question: Long-term earnings outlook - Management confirmed that the long-term earnings potential remains optimistic, with opportunities for margin expansion in Medicaid and Medicare segments [54][56] Question: Impact of public exchange subsidies - Management indicated that the estimate of a $1 impact per share from the potential loss of enhanced APTCs remains valid, with ongoing discussions about the implications of work requirements [57][61] Question: Risk adjustment and membership growth - Management noted that risk adjustment numbers are consistent with expectations, and the majority of new membership remains subsidized, aligning with the company's focus on low-income populations [99][96] Question: Specialty drug trends - Management highlighted that specialty drug utilization trends are being closely monitored, particularly in Medicaid, with high-cost drugs impacting overall costs [118][120]